Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
The CBD industry faced difficulties in 2020 amid competition, regulatory uncertainty and a global pandemic that disrupted retail operations, including:
Continue Reading CBD and Hemp Legal and Regulatory Roundup – May 7, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
A study explored the pain-reducing effects of CBD as well as the
Continue Reading CBD and Hemp Legal and Regulatory Roundup – April 30, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
After seven months of clinical investigation, Validcare’s investigators met with members of the
Continue Reading CBD and Hemp Legal and Regulatory Roundup – March 26, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
With a wide array of CBD
Continue Reading CBD and Hemp Legal and Regulatory Roundup – March 19, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
USPS reminds carriers about mail restrictions for CBD products
Products made with CBD oil have become popular, but there are restrictions when it comes to mailing
Continue Reading CBD and Hemp Legal and Regulatory Roundup
The FTC announced yesterday settlements with six companies accused of making a broad range of unsubstantiated health claims, including that CBD can treat cancer, heart disease, hypertension, Alzheimer’s disease, bipolar disorder, and chronic pain, among others. Nicknamed, “Operation CBDeceit,” the
Continue Reading FTC’s CBD Crackdown: Something Old and Something New
On April 29, the National Advertising Division (“NAD”) recommended that Talyoni Professional, LLC and its affiliate, Ecoco, Inc. (collectively “Talyoni”) discontinue express claims that the companies’ cosmetic and wellness products contain CBD, as well as product performance claims based on
Continue Reading The Proof Is In The Product: National Advertising Division (NAD) Recommends CBD Company Discontinue Claims
In a somewhat mixed decision for cannabis company defendants, a false advertising class action lawsuit will proceed in the Southern District of Florida – and not be halted while waiting for guidance from the FDA – although some of the
Continue Reading Florida Court Permits CBD Mislabeling Case to Proceed
